Home » News & Blog
Disease Control Priorities Network launches a new website
18 Jan 2013
This week, the Disease Control Priorities Network, a research project that CDDEP runs in collaboration with the University of Washington, launched a new website. Read the press release below for more details. *  *  *
Read more »
[comment_count]
Posted by admin
Tags:
Extending the Cure case interview featured in policymaker toolkit for reducing waste and inefficiency in healthcare
17 Jan 2013
Last week Extending the Cure (ETC) staff attended Striving for High Value Health Care: Lessons Learned Across the Country – a roundtable event organized by NEHI, a Boston-based health policy institute dedicated to lowering the cost and improving the quality of US healthcare.
Read more »
[comment_count]
Posted by admin
Tags: antibiotic use, policy
Weekly Digest: Evaluating India’s health insurance scheme, EU tackles resistance, and US health lags
11 Jan 2013
A  roundup of news on drug resistance and other topics in global health.
Read more »
[comment_count]
Posted by Alison Buki
Tags: antibiotic use, antibiotics, disease, drug development, drug resistance, food safety, HAIs, malaria vaccine, new antibiotics, new drugs, policy, resistance, Vaccination
The Health of India’s Health Insurance Scheme for the Poor: White Elephant or White Noise?
10 Jan 2013
There is a growing ideological divide among Indian health researchers and policymakers with respect to the future direction of the country’s health policy. Those in favor of supply-side policies (i.e.
Read more »
[comment_count]
Posted by Arindam Nandi
Tags: community, cost, costs, developing, disease, health, health economics, India, policy, trends
Weekly Digest: New tuberculosis drug approved, Indian ICUs spread infections, and panda DNA to help drug development
4 Jan 2013
A  roundup of news on drug resistance and other topics in global health.
Read more »
[comment_count]
Posted by Suraj Pant
Tags: ACTs, antibiotic use, antibiotics, disease, drug development, environment, flu, health economics, new antibiotics, new drugs, resistance, TB